Knowledge Center

Brochures & Service Guides

Cannabinoids

Unlock the Potential of Your Medicinal Cannabis Products

As the beneficial effects of medicinal cannabis gain greater acceptance and more consumers begin to use cannabis-derived products, there is an ever-increasing need for cultivators to ensure that their products are tested to the required standards to ensure both product safety and quality.

Click to download

Pharmaceutical Nicotine Cannabinoids

Broughton - Your Innovation Partner

Broughton is a leading global contract research organisation specialising in tobacco harm reduction, medicinal cannabis, cannabinoids, and pharmaceuticals, we can help bring category innovators life-enhancing products to market.

Click to download

Cannabinoids

Broughton: Your Medical Cannabis Compliance and Market Entry Partner

As the medical cannabis market grows, expertise in testing, regulatory compliance, and quality control play a pivotal role in assisting category innovators in bringing their products to market.

Click to download

Pharmaceutical Nicotine Cannabinoids

ICH Product Stability Storage and Analysis Brochure

With over 60,000 liters of in-house ICH stability storage capacity, supported by a team of highly qualified scientists and GMP-accredited laboratory testing facilities, we have approximately 250 live studies in progress and offer a full range of stability services to help bring your product to market or ensure its ongoing compliance requirements.

 

Click to download

Cannabinoids

Cannabis Services

Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services. 

Click to download

Cannabinoids

A step by step guide to Cannabis Testing

This guide examines the key steps in the cannabis analytical testing process and what cultivators need to consider when selecting a testing partner.

Click to download

Pharmaceutical Nicotine Cannabinoids

Pharmaceutical Services - Extractables and Leachables

The evaluation of extractables and leachables (E&L) is an essential component of the pharmaceutical development process.

Click to download

Pharmaceutical Nicotine Cannabinoids

Toxicology Advice and Consultancy Services

Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.

Click to download

Cannabinoids

Medicinal Cannabis and CBD Services

Learn more about our UK and EU Novel Food Application scientific consultancy and analytical testing support.

Click to download

Pharmaceutical Nicotine Cannabinoids

Technical Due Diligence: Product Realization Services

Our product development and regulatory experts can help you meet expectations at key milestones in your product development project to better inform decision making and investment choices.

Click to download

Cannabinoids

Ensuring Safety in the Booming CBD Industry: A Proposed Safety Framework

The rapid growth of the cannabis market has outpaced the establishment of comprehensive safety standards and regulations. To help create a pathway towards safe, secure, and reliably-regulated CBD products, Cristelle Santos, Consultant Toxicologist at Broughton, has proposed a safety framework.

Click to download

Pharmaceutical Nicotine Cannabinoids

Quality Policy

We believe that the sectors we work within expect a continually improving service where we constantly strive to improve processes and Quality.

Click to download

Whitepapers

Pharmaceutical Nicotine Cannabinoids

Whitepaper: Designing a Bespoke Stability Study

In this whitepaper, we discuss the stability studies that may be performed during pharmaceutical development and in support of a regulatory dossier to support the licensing of a medicinal drug product.

Click to download

Cannabinoids

Whitepaper: Why Cannabinoid analytical methodologies are the foundations of building a mainstream cannabis industry

In this whitepaper, we discuss the range of validated analytical methods required to support the comprehensive characterization of various dosage forms of cannabinoid products. 

Click to download

Cannabinoids

Whitepaper: Does CBD Really Harm the Liver?

Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.

Click to download

Cannabinoids

Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market

Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route. 

Click to download

Cannabinoids

Whitepaper: The importance of the human endocannabinoid system when developing therapeutic cannabis products

To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.

Click to download

Cannabinoids

Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions

In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD). 

Click to download